Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUTO: Belimumab Plus Standard Therapy in Pediatric SLE
NCT01649765Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2012
- Primary completion
- Jan 2018
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started Sep 2012; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01649765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649765.